Drug Coverage: Dual Eligibles Facing Potential Coverage Lapses

Why This Topic Matters

Coverage disruptions can be especially harmful for beneficiaries with chronic illness and limited ability to navigate plan changes. Understanding the transition issues discussed in the article helps stakeholders assess continuity-of-care protections, operational readiness, and the broader policy debate affecting dual eligibles.

Article Sections

1. Coverage continuity concerns for dual eligibles

   Introduces the policy concerns raised about the move from Medicaid drug coverage to Medicare. It focuses on continuity of care issues for vulnerable beneficiaries and the need for transition safeguards.

2. CMS response and implementation measures

   Summarizes the federal agency’s stated efforts to reduce gaps in drug coverage during the transition. It discusses enrollment support, beneficiary notifications, and plan-level transition planning.

3. Concerns from state and clinical witnesses

   Presents testimony from other hearing participants about the practical challenges of the transition. It highlights concerns about beneficiary readiness, plan requirements, and managed care operations.